How many stocks are there of Zoetis?
The current number of stocks of Zoetis is 462.27 M undefined.
Zoetis Stocks 2024
Zoetis Stocks
462.27 M
Ticker
ZTS
ISIN
US98978V1035
WKN
A1KBYX
In 2024, Zoetis had 462.27 M outstanding stocks, a 0% change from the 462.27 M stocks in the previous year.
The Zoetis Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2030e | 462.27 |
| 2029e | 462.27 |
| 2028e | 462.27 |
| 2027e | 462.27 |
| 2026e | 462.27 |
| 2025e | 462.27 |
| 2024e | 462.27 |
| 2023 | 462.27 |
| 2022 | 470.4 |
| 2021 | 476.7 |
| 2020 | 478.6 |
| 2019 | 481.8 |
| 2018 | 486.9 |
| 2017 | 493.2 |
| 2016 | 498.2 |
| 2015 | 502 |
| 2014 | 502 |
| 2013 | 500.3 |
| 2012 | 500 |
| 2011 | 500 |
| 2010 | 500 |
| 2009 | 500 |
Zoetis shares outstanding US98978V1035 · A1KBYX
The number of shares was Zoetis in 2023 — This indicates how many shares 462.269 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Zoetis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Zoetis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Zoetis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zoetis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2009 | 500 M Aktien |
| 2010 | 500 M Aktien |
| 2011 | 500 M Aktien |
| 2012 | 500 M Aktien |
| 2013 | 500.3 M Aktien |
| 2014 | 502 M Aktien |
| 2015 | 502 M Aktien |
| 2016 | 498.2 M Aktien |
| 2017 | 493.2 M Aktien |
| 2018 | 486.9 M Aktien |
| 2019 | 481.8 M Aktien |
| 2020 | 478.6 M Aktien |
| 2021 | 476.7 M Aktien |
| 2022 | 470.4 M Aktien |
| 2023 | 462.27 M Aktien |
| 2024e | 462.27 M Aktien |
| 2025e | 462.27 M Aktien |
| 2026e | 462.27 M Aktien |
| 2027e | 462.27 M Aktien |
| 2028e | 462.27 M Aktien |
| 2029e | 462.27 M Aktien |
| 2030e | 462.27 M Aktien |
Zoetis Aktienanalyse
What does Zoetis do?
Zoetis Inc. is a leading company in the development and marketing of animal health technology and solutions. The company specializes in innovative products for animals such as dairy cattle, pigs, poultry, dogs, cats, and horses. Zoetis was founded in 1952 as a subsidiary of Pfizer and operated as Pfizer Animal Health. In 2013, the company was finally spun off from Pfizer and became Zoetis Inc. Zoetis focuses on the development, manufacturing, and marketing of products for livestock and pets, including vaccines, pharmaceuticals, biological therapies, and diagnostics. The company operates globally and has its headquarters in Parsippany, New Jersey. Zoetis' business model consists of various business segments divided into animal categories: cattle, pigs, poultry, pets, and horses. Each of these business segments offers specialized solutions for animal owners and veterinarians. In the cattle products segment, Zoetis offers products for dairy cows, beef cattle, and calves. They also provide a variety of prevention and treatment solutions for major animal health issues such as mastitis, reproductive disorders, and respiratory problems. In the swine segment, Zoetis offers prevention and treatment solutions for infectious diseases and parasite control. They also provide products for promoting swine health and weight gain. In the poultry segment, Zoetis offers solutions for the prevention and treatment of infectious diseases. The company's products aim to improve animal health, productivity, and efficiency. Zoetis also offers products for the pet segment, including vaccines, pharmaceuticals, and therapies for dogs, cats, and other pets. Here, the company also provides solutions for major health issues such as heart diseases, pain management, and parasite control. In the horse segment, Zoetis offers solutions for the prevention and treatment of diseases such as equine rhinopneumonia, worm infestations, and arthritis. They also provide products for promoting horse health and performance. Zoetis is known for a variety of innovative products used by animal owners and veterinarians worldwide. One example is ScourGuard® 4KC, a vaccine that protects calves from diarrheal diseases caused by common bacteria. This vaccine has already proven to be highly effective in controlling bowel diseases in calves. Zoetis has also developed and marketed the first FDA-approved product for pain management in dogs (Rimadyl®), as well as the first licensed product for the treatment of giardia in dogs (Panacur®). In summary, Zoetis, as a global leader in the animal health industry, puts innovation and quality at the forefront. With a wide range of products and solutions in various animal categories, Zoetis is a key player in the animal health industry. Zoetis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Zoetis's Shares Outstanding
Zoetis's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Zoetis’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Zoetis’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Zoetis’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Zoetis stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Zoetis are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Zoetis evolved in recent years?
The number of shares of Zoetis has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Zoetis as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Zoetis?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Zoetis pay?
Over the past 12 months, Zoetis paid a dividend of 1.5 USD . This corresponds to a dividend yield of about 0.86 %. For the coming 12 months, Zoetis is expected to pay a dividend of 2.03 USD.
What is the dividend yield of Zoetis?
The current dividend yield of Zoetis is 0.86 %.
When does Zoetis pay dividends?
Zoetis pays a quarterly dividend. This is distributed in the months of February, May, August, November.
How secure is the dividend of Zoetis?
Zoetis paid dividends every year for the past 18 years.
What is the dividend of Zoetis?
For the upcoming 12 months, dividends amounting to 2.03 USD are expected. This corresponds to a dividend yield of 1.16 %.
In which sector is Zoetis located?
Zoetis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zoetis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zoetis from 12/3/2024 amounting to 0.432 USD, you needed to have the stock in your portfolio before the ex-date on 10/31/2024.
When did Zoetis pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Zoetis in the year 2023?
In the year 2023, Zoetis distributed 1.3 USD as dividends.
In which currency does Zoetis pay out the dividend?
The dividends of Zoetis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Zoetis stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank
Andere Kennzahlen von Zoetis
Our stock analysis for Zoetis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zoetis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
